openPR Logo
Press release

New radiation therapy treatment arrives at KHCC

03-28-2011 12:15 PM CET | Health & Medicine

Press release from: King Hussein Cancer Center

Radiation therapy is one of the primary weapons used to fight cancer in modern medicine. Since January 1st 2010, the King Hussein Cancer Centre has begun using a new form of radiation therapy known as IMRT – Intensity Modulated Radiation Therapy. This new technique represents the very latest in medical technology to arrive at the KHCC Radiation Oncology Department, where it is currently being used to successfully treat a range of conditions.

Radiation therapy works by delivering precise doses of radiation to cancerous tumours within the body, with the aim of destroying the tumour’s cells. Doses are usually given through beams directed at the tumour from different angles via a machine, called a linear accelerator – Linac for short. Although effective, radiation therapy often damages healthy body cells as well as cancerous ones since the beams will inevitably hit the tissues and organs surrounding the tumour. However, IMRT works by varying the intensity of the radiation doses, minimising the damage to healthy cells and lessening the side effects of the treatment.

IMRT also makes advances in the planning stage of the treatment. With older forms of radiation therapy hospital physicists would test a number of different beam intensities and angles before the correct dose is given to the patient. With IMRT, physicists attempt the opposite; they decide in advance how much radiation the tumour is to be given. They then feed these numbers into a computer running an inverse IMRT software, which then calculates the appropriate intensities of radiation to be given to the patient as the beam passes over the tumour.

All this adds up to a much safer and less painful experience for many of KHCC’s patients. According to Dr Al Mousa, Chairman of the Department of Radiation Oncology at KHCC, IMRT is very much the way forward:

“It’s an updated form of 3D radiation therapy, but more precise. It saves the normal tissue and decreases the side affects of the treatment. There has also been evidence-based literature that shows the benefits of IMRT, although randomised trials have yet to be carried out. By modulating the intensity of the radiation we can target the tumour more accurately, and reduce the side effects for the patient. For example, patients with tumours in the head or neck often suffer from an acutely dry mouth, after radiation has destroyed the saliva glands. With IMRT, these symptoms are not as severe.”

Leila was a patient at KHCC who recently underwent IMRT, and is able to confirm its effectiveness. Leila came to KHCC for a check-up on the recommendation of her optometrist, after she experienced pain in her eye. A CT scan revealed a tiny tumour in her sinus. Following further tests, including an MRI and a biopsy, the doctors at KHCC decided to put Leila through the new IMRT machines, the first patient with a head tumour to do so

“My sessions lasted for a month, I had them every morning except for weekends. It was the first time I learnt to appreciate my weekends! I went into the room with all the technicians, and then lay down on the machine with my head fixed in place with a custom made mask. The experience is a little harsh, but the staff were amazing and talked me through every single aspect of the treatment. After the treatment I experienced some dryness in my mouth, but not aside from that I felt OK. With my type of treatment there is a risk of fungal infection, but I didn’t experience that at all.”

According to Dr Al Mousa, the new IMRT technique saved Leila a great deal of pain:

“With previous types of radiation therapy treatment to the head or neck would lead to a much more severe symptoms. Patients are often unable to talk for a period of time following treatment. In Leila’s case, no such symptoms occurred and she is doing very well.”

IMRT is a vital advance in medical technology, and it has shown itself to be a highly effective means of treating cancer more efficiently, and with less risk to the patient. KHCC’s use of the new technology ensures the centre remains well equipped to help its patients the very best it can.

The King Hussein Cancer Center (KHCC) is the only specialized cancer center in the Middle East that treats both adult and pediatric patients. Founded in 1997, KHCC is a non-governmental, not-for-profit comprehensive center dedicated entirely to cancer care. It has achieved several international and national recognitions

King Hussein Cancer Center
P.O.BOX 1269 Al-Jubeiha Amman 11941 Jordan

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New radiation therapy treatment arrives at KHCC here

News-ID: 168384 • Views:

More Releases from King Hussein Cancer Center

Sentinel Lymph Node Dissection
Sentinel Lymph Node Dissection
Health care professionals at the King Hussein Cancer Center (KHCC) work tirelessly not only to treat cancer, but to treat the patient with cancer. Doctors are trained in the latest available techniques and findings; employ the most recent proven methods of diagnosis, procedures and treatment; and utilize state-of-the-art medical equipment. KHCC care is patient centric, focusing on the best interests of the patient-aggressively attacking cancer while working to minimize side
Jordan Celebrates World Cancer Day 2011
Jordan Celebrates World Cancer Day 2011
Press Release – Amman - Monday February 8th 2011 – Jordan celebrates World Cancer Day (WCD) 2011 this February along with the global community. The King Hussein Cancer Center (KHCC), The World Health organization (WHO), and the Ministry of Health (MoH) of Jordan have come together to highlight the importance of cancer awareness and cancer control as a theme for the 2011 event. The World Cancer Day is an

More Releases for IMRT

Radiotherapy Market | Ongoing Trends and Recent Developments | Major Key Players …
Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market. What the market looks like? According to
Radiotherapy Market worth $6.8 billion by 2023 | Varian Medical Systems, Inc. (U …
The report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023", The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1% Browse 150 market data Tables and 46 Figures spread through 226 Pages and in-depth
Radiotherapy Market 2024: Analysis By Types, Industry Top Players, Regions & Mar …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. New report title “Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast
Asia Pacific (APAC) Radiotherapy Market Analysis 2017-2024: Varian Medical Syste …
APAC Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) and Forecast to 2024 APAC Radiotherapy Market has accounted for USD 1.1 billion in 2016, and is expected to
Global External Beam Radiotherapy Market Insights by Size, Status and Forecast 2 …
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of External Beam Radiotherapy market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. Some of the key
Global Radiotherapy Market By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomothe …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic),